BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 34013544)

  • 1. Role of cancer-associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer.
    Mhaidly R; Mechta-Grigoriou F
    Immunol Rev; 2021 Jul; 302(1):259-272. PubMed ID: 34013544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies.
    Mhaidly R; Mechta-Grigoriou F
    Semin Immunol; 2020 Apr; 48():101417. PubMed ID: 33077325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
    Eskandari-Malayeri F; Rezaei M
    Front Immunol; 2022; 13():996145. PubMed ID: 36275750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From gatekeepers to providers: regulation of immune functions by cancer-associated fibroblasts.
    Arpinati L; Scherz-Shouval R
    Trends Cancer; 2023 May; 9(5):421-443. PubMed ID: 36870916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The heterogeneity of cancer-associated fibroblast subpopulations: Their origins, biomarkers, and roles in the tumor microenvironment.
    Yamamoto Y; Kasashima H; Fukui Y; Tsujio G; Yashiro M; Maeda K
    Cancer Sci; 2023 Jan; 114(1):16-24. PubMed ID: 36197901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-Associated Fibroblasts Suppress CD8+ T-cell Infiltration and Confer Resistance to Immune-Checkpoint Blockade.
    Jenkins L; Jungwirth U; Avgustinova A; Iravani M; Mills A; Haider S; Harper J; Isacke CM
    Cancer Res; 2022 Aug; 82(16):2904-2917. PubMed ID: 35749591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pan-cancer analyses and molecular subtypes based on the cancer-associated fibroblast landscape and tumor microenvironment infiltration characterization reveal clinical outcome and immunotherapy response in epithelial ovarian cancer.
    Zou R; Jiang Q; Jin T; Chen M; Yao L; Ding H
    Front Immunol; 2022; 13():956224. PubMed ID: 36032075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
    Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
    Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between cancer-associated fibroblasts and T-cells: functional crosstalk with targeting and biomarker potential.
    Milosevic V; Östman A
    Ups J Med Sci; 2024; 129():. PubMed ID: 38863724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated fibroblast spatial heterogeneity and
    Honda CK; Kurozumi S; Fujii T; Pourquier D; Khellaf L; Boissiere F; Horiguchi J; Oyama T; Shirabe K; Colinge J; Yokobori T; Turtoi A
    Theranostics; 2024; 14(5):1873-1885. PubMed ID: 38505604
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime.
    Pradip D; Jennifer A; Nandini D
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials.
    Zhang H; Yue X; Chen Z; Liu C; Wu W; Zhang N; Liu Z; Yang L; Jiang Q; Cheng Q; Luo P; Liu G
    Mol Cancer; 2023 Oct; 22(1):159. PubMed ID: 37784082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-associated fibroblasts: heterogeneity and their role in the tumor immune response.
    Xiao Y; Wang Z; Gu M; Wei P; Wang X; Li W
    Clin Exp Med; 2024 Jun; 24(1):126. PubMed ID: 38864912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer.
    Liu W; Wang M; Wang M; Liu M
    Medicine (Baltimore); 2023 Aug; 102(32):e34611. PubMed ID: 37565899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis in the Pancreatic Cancer Tumor Microenvironment-The Double-Edged Sword of Cancer-Associated Fibroblasts.
    Pfeifer E; Burchell JM; Dazzi F; Sarker D; Beatson R
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of human prostate carcinoma-associated fibroblasts implicates a role for subpopulations in myeloid cell recruitment.
    Vickman RE; Broman MM; Lanman NA; Franco OE; Sudyanti PAG; Ni Y; Ji Y; Helfand BT; Petkewicz J; Paterakos MC; Crawford SE; Ratliff TL; Hayward SW
    Prostate; 2020 Feb; 80(2):173-185. PubMed ID: 31763714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-Associated Fibroblast Subpopulations With Diverse and Dynamic Roles in the Tumor Microenvironment.
    Simon T; Salhia B
    Mol Cancer Res; 2022 Feb; 20(2):183-192. PubMed ID: 34670861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated fibroblasts: Origin, function, imaging, and therapeutic targeting.
    Rimal R; Desai P; Daware R; Hosseinnejad A; Prakash J; Lammers T; Singh S
    Adv Drug Deliv Rev; 2022 Oct; 189():114504. PubMed ID: 35998825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell Component and Function of Tumor Microenvironment in Thyroid Cancer.
    Shin E; Koo JS
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.